{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:53:58Z","timestamp":1760057638383,"version":"build-2065373602"},"reference-count":27,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis characterized by rapidly developing, painful ulcerative lesions. It exhibits pathergy, a phenomenon in which minor trauma or injury to the skin triggers an exaggerated inflammatory response. This leads to the development of new skin lesions or the worsening of existing ones. Treatment typically involves a combination of corticosteroids and immunosuppressive agents. However, even with effective therapy, the overall management of pyoderma gangrenosum remains challenging, and wound healing can be prolonged. The development of pyoderma gangrenosum after breast cancer surgery is rare, and its presence complicates the treatment of patients requiring additional oncologic therapy. In particular, the effect of radiation on these lesions is not well documented. Given the known skin toxicity of radiotherapy and its negative impact on wound healing, the use of adjuvant breast radiation raises significant concerns in this context. Methods: We present the case of a 66-year-old female with Stage IIB invasive ductal carcinoma of the left breast who developed postoperative pyoderma gangrenosum after breast-conserving surgery. The patient was treated with systemic corticosteroids and cyclosporine, and then subsequently underwent standard-of-care adjuvant chemotherapy and radiation. Results: During therapy, she demonstrated rapid resolution of her pyoderma gangrenosum without experiencing excess skin toxicity. Conclusions: While the literature on the direct application of radiation in pyoderma gangrenosum is limited, our case provides evidence supporting the safety of radiation therapy in oncologic cases complicated by this disease. In addition to receiving the benefit of adjuvant therapy for her breast cancer, our patient demonstrated an improvement in her postoperative PG with no adverse skin effects.<\/jats:p>","DOI":"10.3390\/jcm14041320","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T03:41:47Z","timestamp":1739763707000},"page":"1320","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Resolution of Pyoderma Gangrenosum During Adjuvant Breast Cancer Therapy"],"prefix":"10.3390","volume":"14","author":[{"given":"Abigail P.","family":"Lauder","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology and Applied Sciences, Dartmouth Hitchcock Medical Center, Lebanon, NH 03756, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Nwiloh","sequence":"additional","affiliation":[{"name":"Meharry Medical College School of Medicine, Meharry Medical College, Nashville, TN 37208, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Eximond","sequence":"additional","affiliation":[{"name":"DeBusk College of Osteopathic Medicine, Lincoln Memorial University, Knoxville, TN 37752, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8551-0381","authenticated-orcid":false,"given":"Robert E.","family":"LeBlanc","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Dartmouth Hitchcock Medical Center, Lebanon, NH 03756, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2347-5602","authenticated-orcid":false,"given":"Alicia T.","family":"Dagrosa","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Dartmouth Hitchcock Medical Center, Lebanon, NH 03756, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Barth","sequence":"additional","affiliation":[{"name":"Department of Surgery, Dartmouth Hitchcock Medical Center, Lebanon, NH 03756, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Chamberlin","sequence":"additional","affiliation":[{"name":"Department of Medicine, Dartmouth Hitchcock Medical Center, Lebanon, NH 03756, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0273-8071","authenticated-orcid":false,"given":"Shauna","family":"McVorran","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology and Applied Sciences, Dartmouth Hitchcock Medical Center, Lebanon, NH 03756, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s40257-017-0251-7","article-title":"Pyoderma Gangrenosum: An Update on Pathophysiology, Diagnosis and Treatment","volume":"18","author":"Alavi","year":"2017","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/bjd.13955","article-title":"Pyoderma gangrenosum and Sweet syndrome: The prototypic neutrophilic dermatoses","volume":"178","author":"Wallach","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1038\/jid.2012.130","article-title":"Incidence, mortality, and disease associations of pyoderma gangrenosum in the United Kingdom: A retrospective cohort study","volume":"132","author":"Langan","year":"2012","journal-title":"J. Investig. Dermatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/jamadermatol.2017.5978","article-title":"The Association of Age With Clinical Presentation and Comorbidities of Pyoderma Gangrenosum","volume":"154","author":"Ashchyan","year":"2018","journal-title":"JAMA Dermatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s40257-018-0356-7","article-title":"Underlying Systemic Diseases in Pyoderma Gangrenosum: A Systematic Review and Meta-Analysis","volume":"19","author":"Kridin","year":"2018","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/ijd.14637","article-title":"Paraneoplastic pyoderma gangrenosum in solid organ malignancy: A literature review","volume":"59","author":"Shah","year":"2020","journal-title":"Int. J. Dermatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.bjps.2014.12.036","article-title":"A systematic review of post-surgical pyoderma gangrenosum: Identification of risk factors and proposed management strategy","volume":"68","author":"Zuo","year":"2015","journal-title":"J. Plast. Reconstr. Aesthetic Surg."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Chen, B., Li, W., and Qu, B. (2023). Practical aspects of the diagnosis and management of pyoderma gangrenosum. Front. Med., 10.","DOI":"10.3389\/fmed.2023.1134939"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1742-4801.2005.00079.x","article-title":"Radiotherapy and wound healing","volume":"2","author":"Dormand","year":"2005","journal-title":"Int. Wound J."},{"key":"ref_10","unstructured":"D\u2019Orsi, C.J., Sickles, E.A., Mendelson, E.B., and Morris, E.A. (2013). ACR BI-RADS Atlas, Breast Imaging Reporting and Data System, American College of Radiology."},{"key":"ref_11","unstructured":"Amin, M.B., Edge, S.B., Greene, F.L., and Trotti, A. (2017). AJCC Cancer Staging Manual, Springer. [8th ed.]."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s40265-023-01931-3","article-title":"Pyoderma Gangrenosum: Treatment Options","volume":"83","author":"Dissemond","year":"2023","journal-title":"Drugs"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2165\/11595240-000000000-00000","article-title":"Etiology and management of pyoderma gangrenosum: A comprehensive review","volume":"13","author":"Ahronowitz","year":"2012","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jaad.2015.06.021","article-title":"Pathophysiology of pyoderma gangrenosum (PG): An updated review","volume":"73","author":"Braswell","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Yoshimura, A., Imoto, I., and Iwata, H. (2022). Functions of Breast Cancer Predisposition Genes: Implications for Clinical Management. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23137481"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.jaad.2009.02.033","article-title":"Disseminated pyoderma gangrenosum: Role for vascular endothelial growth factor and hypoxia inducible factor-2","volume":"61","author":"Chua","year":"2009","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1365-2249.2010.04201.x","article-title":"Role of inflammatory cells, cytokines and matrix metalloproteinases in neutrophil-mediated skin diseases","volume":"162","author":"Marzano","year":"2010","journal-title":"Clin. Exp. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/cei.12394","article-title":"Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet\u2019s syndrome","volume":"178","author":"Marzano","year":"2014","journal-title":"Clin. Exp. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"101516","DOI":"10.1016\/j.smim.2021.101516","article-title":"G-CSF\u2014A double edge sword in neutrophil mediated immunity","volume":"54","author":"Martin","year":"2021","journal-title":"Semin Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0190-9622(96)90285-6","article-title":"Treatment of pyoderma gangrenosum","volume":"34","author":"Chow","year":"1996","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jaad.2004.10.006","article-title":"Treatment recommendations for pyoderma gangrenosum: An evidence-based review of the literature based on more than 350 patients","volume":"53","author":"Reichrath","year":"2005","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/gut.2005.074815","article-title":"Infliximab for the treatment of pyoderma gangrenosum: A randomised, double blind, placebo controlled trial","volume":"55","author":"Brooklyn","year":"2006","journal-title":"Gut"},{"key":"ref_23","first-page":"689","article-title":"Intravenous cyclophosphamide pulses in pyoderma gangrenosum: An open trial","volume":"24","year":"1997","journal-title":"J. Rheumatol."},{"key":"ref_24","first-page":"145","article-title":"Radiation therapy for recalcitrant pyoderma gangrenosum","volume":"149","author":"Rumeileh","year":"2014","journal-title":"G Ital. Dermatol. Venereol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/bjc.1997.119","article-title":"Radiation-induced apoptosis in microvascular endothelial cells","volume":"75","author":"Langley","year":"1997","journal-title":"Br. J. Cancer"},{"key":"ref_26","first-page":"3276","article-title":"Effects of radiation on T regulatory cells in normal states and cancer: Mechanisms and clinical implications","volume":"5","author":"Liu","year":"2015","journal-title":"Am. J. Cancer Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/1523-1747.ep12384118","article-title":"Expression of 72-kDa gelatinase (MMP-2), collagenase (MMP-1), and tissue metalloproteinase inhibitor (TIMP) in primary pig skin fibroblast cultures derived from radiation-induced skin fibrosis","volume":"102","author":"Lafuma","year":"1994","journal-title":"J. Investig. Dermatol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/4\/1320\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:35:49Z","timestamp":1760027749000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/4\/1320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,17]]},"references-count":27,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["jcm14041320"],"URL":"https:\/\/doi.org\/10.3390\/jcm14041320","relation":{},"ISSN":["2077-0383"],"issn-type":[{"type":"electronic","value":"2077-0383"}],"subject":[],"published":{"date-parts":[[2025,2,17]]}}}